220 related articles for article (PubMed ID: 32260293)
1. Advances on Chelation and Chelator Metal Complexes in Medicine.
Kontoghiorghes GJ
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260293
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Metal Homeostasis for Cancer Therapy.
Yang Y; Fan H; Guo Z
Chempluschem; 2024 Jun; 89(6):e202300624. PubMed ID: 38315756
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and cytotoxicity studies of Cu(II), Zn(II), and Fe(III) complexes of N-derivatized 3-hydroxy-4-pyridiones.
Telpoukhovskaia MA; Rodríguez-Rodríguez C; Scott LE; Page BD; Patrick BO; Orvig C
J Inorg Biochem; 2014 Mar; 132():59-66. PubMed ID: 24393377
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine.
Timoshnikov VA; Selyutina OY; Polyakov NE; Didichenko V; Kontoghiorghes GJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163169
[TBL] [Abstract][Full Text] [Related]
5. Preparation of Tetradentate Copper Chelators as Potential Anti-Alzheimer Agents.
Zhang W; Huang D; Huang M; Huang J; Wang D; Liu X; Nguyen M; Vendier L; Mazères S; Robert A; Liu Y; Meunier B
ChemMedChem; 2018 Apr; 13(7):684-704. PubMed ID: 29420864
[TBL] [Abstract][Full Text] [Related]
6. Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions.
Peana M; Medici S; Nurchi VM; Lachowicz JI; Crisponi G; Garribba E; Sanna D; Zoroddu MA
J Inorg Biochem; 2017 Jun; 171():18-28. PubMed ID: 28343065
[TBL] [Abstract][Full Text] [Related]
7. Complex formation equilibria of polyamine ligands with copper(II) and zinc(II).
Nurchi VM; Crisponi G; Sanna G; Pérez-Toro I; Niclos-Gutierrez J; Gonzalez-Perez MJ; Domínguez Martín A
J Inorg Biochem; 2019 May; 194():26-33. PubMed ID: 30807891
[TBL] [Abstract][Full Text] [Related]
8. Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease.
Robert A; Liu Y; Nguyen M; Meunier B
Acc Chem Res; 2015 May; 48(5):1332-9. PubMed ID: 25946460
[TBL] [Abstract][Full Text] [Related]
9. Characterization of new specific copper chelators as potential drugs for the treatment of Alzheimer's disease.
Nguyen M; Robert A; Sournia-Saquet A; Vendier L; Meunier B
Chemistry; 2014 May; 20(22):6771-85. PubMed ID: 24797103
[TBL] [Abstract][Full Text] [Related]
10. Metal Chelation Therapy and Parkinson's Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs.
Tosato M; Di Marco V
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31324037
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamics-based rules of thumb to evaluate the interaction of chelators and kinetically-labile metal ions in blood serum and plasma.
Falcone E; Faller P
Dalton Trans; 2023 Feb; 52(8):2197-2208. PubMed ID: 36734607
[TBL] [Abstract][Full Text] [Related]
12. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
13. Thermodynamic remarks on chelating ligands for aluminium related diseases.
Crisponi G; Nurchi VM
J Inorg Biochem; 2011 Nov; 105(11):1518-22. PubMed ID: 22099162
[TBL] [Abstract][Full Text] [Related]
14. The chelation targeting metal-Aβ40 aggregates may lead to formation of Aβ40 oligomers.
Zhang Y; Chen LY; Yin WX; Yin J; Zhang SB; Liu CL
Dalton Trans; 2011 May; 40(18):4830-3. PubMed ID: 21437337
[TBL] [Abstract][Full Text] [Related]
15. Chelators controlling metal metabolism and toxicity pathways: applications in cancer prevention, diagnosis and treatment.
Kontoghiorghes GJ; Efstathiou A; Ioannou-Loucaides S; Kolnagou A
Hemoglobin; 2008; 32(1-2):217-27. PubMed ID: 18274999
[TBL] [Abstract][Full Text] [Related]
16. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
[TBL] [Abstract][Full Text] [Related]
17. New cyclodextrin-bearing 8-hydroxyquinoline ligands as multifunctional molecules.
Oliveri V; Puglisi A; Viale M; Aiello C; Sgarlata C; Vecchio G; Clarke J; Milton J; Spencer J
Chemistry; 2013 Oct; 19(41):13946-55. PubMed ID: 24038335
[TBL] [Abstract][Full Text] [Related]
18. Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators.
Lachowicz JI; Nurchi VM; Crisponi G; Jaraquemada-Pelaez Mde G; Ostrowska M; Jezierska J; Gumienna-Kontecka E; Peana M; Zoroddu MA; Choquesillo-Lazarte D; Niclós-Gutiérrez J; González-Pérez JM
J Inorg Biochem; 2015 Oct; 151():94-106. PubMed ID: 26281974
[TBL] [Abstract][Full Text] [Related]
19. Studies on transition metal-quercetin complexes using electrospray ionization tandem mass spectrometry.
Liu Y; Guo M
Molecules; 2015 May; 20(5):8583-94. PubMed ID: 25985359
[TBL] [Abstract][Full Text] [Related]
20. A Speciation Study on the Perturbing Effects of Iron Chelators on the Homeostasis of Essential Metal Ions.
Crisponi G; Nurchi VM; Crespo-Alonso M; Sanna G; Zoroddu MA; Alberti G; Biesuz R
PLoS One; 2015; 10(7):e0133050. PubMed ID: 26192307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
